BioCentury
ARTICLE | Company News

Pharsight pops on Millennium deal

July 18, 2001 7:00 AM UTC

PHST was up $0.80 (48%) to $2.45 on Wednesday after the company's post-market announcement on Tuesday that Millennium (MLNM) will evaluate its computer-based trial design and decision software. MLNM i...